Ok well if you’re an investor - just wait. And watch this place be run into the ground. If you’re upper management or CLT you should be hearing the reps comments on where the pitfalls are.
If you think reps took jobs at Phathom, and wanted Voquezna to do anything else but be successful you are sorely mistaken. Every rep here has a pride for this incredible drug. The safety, the efficacy, the way it positively impacts lives. We are directly interfacing with providers. We want this drug to be successful.
Why isn’t anyone in CLT troubleshooting?